You've made another misleading statement, it's bloody in Ph1 so how can you compare this to commercially available or clinically strong OV therapies right now. That's why the percentage you keep quoting is currently low, we are waiting for the next clinical trial update after they achieved a CR in such low dosage where you even stated was "excellent" result. And there has been peer review publication indicating CF33 is working as expected.
"3. The preclinical evidence supporting CF33 is weak in general with no peer reviewed published material demonstrating CF33 is better than commercially available or clinically strong OV therapies.:
Also, another misleading statement which you've been corrected on but continue to state as "truth", CG0070 has moved to Ph3 clinical trial a few years ago. Yes, "if" like you said, CF33 doesn't work as expected then there's still Azer-Cel, HER-Vaxx with excellent Ph2 results and PD1-Vaxx which has moved to Ph2 clinical trial
https://ascopubs.org/doi/10.1200/JCO.2022.40.6_suppl.TPS598
You've made another misleading statement, it's bloody in Ph1 so...
-
- There are more pages in this discussion • 784 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |